<SEC-DOCUMENT>0001140361-25-042491-index.html : 20251117
<SEC-HEADER>0001140361-25-042491.hdr.sgml : 20251117
<ACCEPTANCE-DATETIME>20251117162253
ACCESSION NUMBER:		0001140361-25-042491
CONFORMED SUBMISSION TYPE:	10-Q/A
PUBLIC DOCUMENT COUNT:		14
CONFORMED PERIOD OF REPORT:	20250930
FILED AS OF DATE:		20251117
DATE AS OF CHANGE:		20251117

FILER:

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			Grace Therapeutics, Inc.
		CENTRAL INDEX KEY:			0001444192
		STANDARD INDUSTRIAL CLASSIFICATION:	PHARMACEUTICAL PREPARATIONS [2834]
		ORGANIZATION NAME:           	03 Life Sciences
		EIN:				000000000
		STATE OF INCORPORATION:			DE
		FISCAL YEAR END:			0331

	FILING VALUES:
		FORM TYPE:		10-Q/A
		SEC ACT:		1934 Act
		SEC FILE NUMBER:	001-35776
		FILM NUMBER:		251491328

	BUSINESS ADDRESS:	
		STREET 1:		103 CARNEGIE CENTER
		STREET 2:		SUITE 300
		CITY:			PRINCETON
		STATE:			NJ
		ZIP:			08540
		BUSINESS PHONE:		609-322-1602

	MAIL ADDRESS:	
		STREET 1:		103 CARNEGIE CENTER
		STREET 2:		SUITE 300
		CITY:			PRINCETON
		STATE:			NJ
		ZIP:			08540

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	Acasti Pharma Inc.
		DATE OF NAME CHANGE:	20080828
</SEC-HEADER>
<DOCUMENT>
<TYPE>10-Q/A
<SEQUENCE>1
<FILENAME>ef20059408_10qa.htm
<DESCRIPTION>10Q/A
<TEXT>
Document 1 - file: ef20059408_10qa.htm

</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.SCH
<SEQUENCE>2
<FILENAME>grce-20250930.xsd
<DESCRIPTION>INLINE XBRL TAXONOMY EXTENSION - SCHEMA
<TEXT>
Document 2 - file: grce-20250930.xsd

</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.LAB
<SEQUENCE>3
<FILENAME>grce-20250930_lab.xml
<DESCRIPTION>INLINE XBRL TAXONOMY EXTENSION - LABEL LINKBASE
<TEXT>
Document 3 - file: grce-20250930_lab.xml

</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.PRE
<SEQUENCE>4
<FILENAME>grce-20250930_pre.xml
<DESCRIPTION>INLINE XBRL TAXONOMY EXTENSION - PRESENTATION LINKBASE
<TEXT>
Document 4 - file: grce-20250930_pre.xml

</DOCUMENT>
<DOCUMENT>
<TYPE>EX-31.1
<SEQUENCE>5
<FILENAME>ef20059408_ex31-1.htm
<DESCRIPTION>EXHIBIT 31.1
<TEXT>
Document 5 - file: ef20059408_ex31-1.htm

</DOCUMENT>
<DOCUMENT>
<TYPE>EX-31.2
<SEQUENCE>6
<FILENAME>ef20059408_ex31-2.htm
<DESCRIPTION>EXHIBIT 31.2
<TEXT>
Document 6 - file: ef20059408_ex31-2.htm

</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>8
<FILENAME>R1.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
Document 8 - file: R1.htm

</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>9
<FILENAME>Show.js
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
Document 9 - file: Show.js

</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>10
<FILENAME>report.css
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
Document 10 - file: report.css

</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>12
<FILENAME>FilingSummary.xml
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
Document 12 - file: FilingSummary.html

Document 12 - RAW XML: FilingSummary.xml

</DOCUMENT>
<DOCUMENT>
<TYPE>JSON
<SEQUENCE>14
<FILENAME>MetaLinks.json
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
Document 14 - file: MetaLinks.json

</DOCUMENT>
<DOCUMENT>
<TYPE>ZIP
<SEQUENCE>15
<FILENAME>0001140361-25-042491-xbrl.zip
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
Document 15 - file: 0001140361-25-042491-xbrl.zip

</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>16
<FILENAME>ef20059408_10qa_htm.xml
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
Document 16 - file: ef20059408_10qa_htm.html

Document 16 - RAW XML: ef20059408_10qa_htm.xml

</DOCUMENT>
</SEC-DOCUMENT>